Literature DB >> 31260369

The Role Of Social Risk Factors In Dialysis Facility Ratings And Penalties Under A Medicare Quality Incentive Program.

Andrew C Qi1, Anne M Butler2, Karen E Joynt Maddox3.   

Abstract

Medicare's End-Stage Renal Disease Quality Incentive Program is a mandatory pay-for-performance program for US dialysis facilities, in which facilities are penalized up to 2 percent of their total Medicare payments based on their performance on quality metrics. While analyses of similar programs in other settings have shown performance to be related to social risk factors, it is unknown whether this program displays similar patterns. In this national study, facilities located in low-income ZIP codes and with high proportions of patients who were black or dually enrolled in Medicaid had lower performance scores and higher rates of penalization under the program. Independent (versus chain) status, large facility size, and urban location were also associated with penalties. Further study is needed to determine the degree to which these patterns reflect low-quality care delivery versus patient factors beyond providers' control. In the meantime, the impact of these penalties on providers serving vulnerable populations should be tracked closely.

Entities:  

Keywords:  Medicare; Value-based Payment; dialysis; quality

Year:  2019        PMID: 31260369     DOI: 10.1377/hlthaff.2018.05406

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  5 in total

1.  The Dialysis Safety Net: Who Cares for Those Without Medicare?

Authors:  Rebecca Thorsness; Amal N Trivedi
Journal:  J Am Soc Nephrol       Date:  2020-01-24       Impact factor: 10.121

2.  Initial Home Dialysis Is Increased for Rural Patients by Accessing Urban Facilities.

Authors:  Joel T Adler; S Ali Husain; Lingwei Xiang; James R Rodrigue; Sushrut S Waikar
Journal:  Kidney360       Date:  2022-01-04

3.  Association of Social Risk Factors With Home Dialysis and Kidney Transplant Rates in Dialysis Facilities.

Authors:  Rebecca Thorsness; Virginia Wang; Rachel E Patzer; Kelsey Drewry; Vincent Mor; Momotazur Rahman; Amal N Trivedi
Journal:  JAMA       Date:  2021-12-14       Impact factor: 56.272

Review 4.  Value-Based Care and Kidney Disease: Emergence and Future Opportunities.

Authors:  Sri Lekha Tummalapalli; Mallika L Mendu
Journal:  Adv Chronic Kidney Dis       Date:  2022-01       Impact factor: 4.305

5.  Toward Antiracist Reimbursement Policy in End-Stage Kidney Disease: From Equality to Equity.

Authors:  Kathryn Taylor; Deidra C Crews
Journal:  J Am Soc Nephrol       Date:  2021-07-12       Impact factor: 14.978

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.